Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kissei Pharmaceutical Co ( (JP:4547) ) has shared an announcement.
Kissei Pharmaceutical has announced its new five-year management plan, ‘Beyond 80,’ which aims to build on the successes of its previous plan, PEGASUS. The company exceeded its sales targets in 2024 and plans to continue its growth by expanding its R&D pipeline, launching new products, and increasing its international presence. The ‘Beyond 80’ plan focuses on sustainable growth, environmental management, and achieving significant financial metrics, such as an ROE of over 8% and a 10-year average growth rate of over 5% in sales.
More about Kissei Pharmaceutical Co
Kissei Pharmaceutical Co., Ltd. is an R&D-oriented pharmaceutical company based in Matsumoto, Nagano, Japan. It focuses on drug discovery and the commercialization of pharmaceutical products both domestically and internationally, with a commitment to sustainable growth and societal contributions.
Average Trading Volume: 72,057
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen160.2B
Find detailed analytics on 4547 stock on TipRanks’ Stock Analysis page.